Isomorphic Labs
Focused on designing and developing new medicines with AI, scaling its proprietary drug design engine (IsoDDE). isomorphiclabs.com
Funding
- $5B Series C, announced November 17, 2026. Led by Greenoaks and Sequoia Capital. Co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz, Alphabet, Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund participating. Listed in the AI startup funding roster for November 16–21, 2026. Sources: Isomorphic Labs announcement, Tech.eu.
Of the 24 Series C rounds with exactly stated amounts in dollars on Presspool's weekly rosters since September 21, 2026, Isomorphic Labs' $5B is the largest; their median is $150 million.
Whether AI names Isomorphic Labs
- Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to November 21, 2026.
Related records
Closest rounds in the roster for November 16–21, 2026: Payhawk ($280M Series C, November 18, 2026), Numa ($45 million Series C, November 16, 2026), ODAIA ($15M Series C, November 17, 2026), MedInTech (KRW 33.8 billion Series C, November 17, 2026), Genesis AI ($500M Series A, November 17, 2026), Model ML ($250M Series B, November 17, 2026).
Greenoaks, which led this round, is named as an investor in Payhawk ($280M Series C, November 18, 2026) and Pigment ($250 million Series E, October 21, 2026).
Sequoia Capital, which led this round, also led Serval ($150 million Series C, October 29, 2026), Catalyst ($30M Seed, October 8, 2026), Healthleap ($38 million Seed and Series A, October 7, 2026), Mecka ($60 million Series B, October 7, 2026), Parallel Web Systems ($100M Series B, April 29, 2026) and ElevenLabs ($500M Series D, February 4, 2026). 3 more of its rounds are on its page.